Tower Research Capital LLC (Trc) Armata Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,312 shares of ARMP stock, worth $6,888. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,312
Previous 2,005
65.19%
Holding current value
$6,888
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ARMP
# of Institutions
25Shares Held
1.39MCall Options Held
0Put Options Held
10.3K-
Bank Of America Corp Charlotte, NC634KShares$1.32 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA234KShares$486,9670.0% of portfolio
-
Geode Capital Management, LLC Boston, MA107KShares$222,1210.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$208,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX69.7KShares$144,9380.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $75.2M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...